Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_assertion type Assertion NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_head.
- NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_assertion description "[The results showed a higher frequency of the ECRG2 TCA (3)/TCA (4) genotype in cancer patients than in controls (odds ratio 2.6, 95% CI 1.0-6.4, p = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_provenance.
- NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_assertion evidence source_evidence_literature NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_provenance.
- NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_assertion SIO_000772 18618216 NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_provenance.
- NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_assertion wasDerivedFrom befree-20150227 NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_provenance.
- NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_assertion wasGeneratedBy ECO_0000203 NP686762.RAVT66kQsg8e0ar9Jp7S0tFq8xXa8jr-drEoeLwN3fAJM130_provenance.